EROĞLU, A. Et Al. 2017. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , vol.26, no.2 , 245-249.

EROĞLU, A., CANSIZ ERSÖZ, C., Karasoy, D., & SAK, S., (2017). Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , vol.26, no.2, 245-249.

EROĞLU, AYDAN Et Al. "Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis," ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , vol.26, no.2, 245-249, 2017

EROĞLU, AYDAN Et Al. "Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis." ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , vol.26, no.2, pp.245-249, 2017

EROĞLU, A. Et Al. (2017) . "Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis." ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , vol.26, no.2, pp.245-249.

@article{article, author={AYDAN EROĞLU Et Al. }, title={Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis}, journal={ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE}, year=2017, pages={245-249} }